Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;34(2):341-347.
doi: 10.1007/s40520-021-01935-7. Epub 2021 Jul 20.

Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment

Wataru Araki  1 , Kazutomi Kanemaru  2 , Kotaro Hattori  3 , Tadashi Tsukamoto  4 , Yuko Saito  4 , Sumiko Yoshida  4 , Harumasa Takano  4 , Masuhiro Sakata  4 , Yuma Yokoi  4 , Yoshie Omachi  4 , Utako Nagaoka  5 , Masahiro Nagao  5 , Takashi Komori  5 , Hisateru Tachimori  6 , Shigeo Murayama  2 , Hidehiro Mizusawa  4
Affiliations

Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment

Wataru Araki et al. Aging Clin Exp Res. 2022 Feb.

Abstract

Objectives: Concentrations of soluble amyloid precursor proteins-α (sAPPα) and -β (sAPPβ) in cerebrospinal fluid (CSF) may reflect the neuropathology of Alzheimer's disease (AD). We previously reported that the concentrations of both sAPPα and sAPPβ were significantly higher in patients with mild cognitive impairment (MCI) due to AD (MCI-AD) than in control subjects without cognitive impairment. The present study analyzed whether these sAPPs are useful in the differential diagnosis of MCI.

Methods: A modified and sensitive method was used to analyze concentrations of sAPPα and sAPPβ in CSF of patients with MCI-AD (n = 30) and MCI due to other causes (MCI-others) (n = 24). Phosphorylated tau (p-tau) and amyloid β-protein 42 (Aβ42) were also analyzed using standard methods.

Results: CSF concentrations of sAPPα and sAPPβ were significantly higher in the MCI-AD than in the MCI-others group (p < 0.001). Furthermore, concentrations of both sAPPα and sAPPβ were highly correlated with the concentration of p-tau, consistent with our previous report.

Conclusions: Measurement of both sAPPs in CSF using sensitive methods can be helpful in the precise differential diagnosis of patients with MCI.

Keywords: Alzheimer’s disease; Biomarker; Cerebrospinal fluid; Mild cognitive impairment; Soluble amyloid precursor protein; Tau.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Petersen RC (2016) Mild cognitive impairment. Continuum (Minneap Minn) 22:404–418. https://doi.org/10.1212/CON.0000000000000313 - DOI
    1. Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279. https://doi.org/10.1016/j.jalz.2011.03.008 - DOI - PubMed - PMC
    1. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36. https://doi.org/10.1007/s00401-009-0532-1 - DOI - PubMed
    1. Johnson KA, Schultz A, Betensky RA et al (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79:110–119. https://doi.org/10.1002/ana.24546 - DOI - PubMed
    1. Chandra A, Valkimadi PE, Pagano G et al (2019) Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment. Hum Brain Mapp 40:5424–5442. https://doi.org/10.1002/hbm.24782 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources